Key result
Intravenous nicardipine used for tocolysis in pregnant patients can cause acute pulmonary edema, a rare but severe complication requiring ICU admission.
Case Report (n=4)
Intravenous nicardipine used for tocolysis can cause severe acute pulmonary edema in pregnant patients without prior heart disease.
Nicardipine tocolysis may precipitate acute pulmonary edema; this case report leaves open incidence, risk factors, and monitoring needs.
We report four cases of acute pulmonary edema that occurred during treatment by intravenous tocolysis using nicardipine in pregnancy patients with no previous heart problems. Clinical severity justified hospitalization in intensive care unit (ICU) each time. Acute dyspnea has begun at an average of 63 hours after initiation of treatment. For all patients, the first diagnosis suspected was pulmonary embolism. The patients' condition improved rapidly with appropriate diuretic treatment and by modifying the tocolysis. The use of intravenous nicardipine is widely used for tocolysis in France even if its prescription does not have a marketing authorization. The pathophysiological mechanisms of this complication remain unclear. The main reported risk factors are spontaneous preterm labor, multiple pregnancy, concomitant obstetrical disease, association with beta-agonists, and fetal lung maturation corticotherapy. A better knowledge of this rare but serious adverse event should improve the management of patients. Nifedipine or atosiban, the efficiency of which tocolysis was also studied, could be an alternative.
No takes yet. Share an insight, caveat, or question.
Serena et al. (2014) conducted a case report in Pregnancy requiring tocolysis (n=4). Intravenous nicardipine was evaluated on Acute pulmonary edema. Intravenous nicardipine used for tocolysis in pregnant patients can cause acute pulmonary edema, a rare but severe complication requiring ICU admission.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: